![Mateja Vrecer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Mateja Vrecer has held positions at KRKA dd and KRKA Farmaceutici Milano SRL.
Currently, Dr. Vrecer is an Independent Member-Supervisory Board at KRKA dd and a Member-Supervisory Board at KRKA Farmaceutici Milano SRL.
Actieve functies van Mateja Vrecer
Bedrijven | Functie | Begin |
---|---|---|
KRKA, D. D. | Directeur/Bestuurslid | 01-01-2005 |
KRKA Farmaceutici Milano SRL
![]() KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Directeur/Bestuurslid | 01-01-2005 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
KRKA, D. D. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
KRKA Farmaceutici Milano SRL
![]() KRKA Farmaceutici Milano SRL Pharmaceuticals: MajorHealth Technology Part of KRKA dd, KRKA Farmaceutici Milano SRL is a leading Italian generic pharmaceutical company with nearly 70 years of experience. The company is based in Milan, Italy. We use modern technologies and our own analytical methods to develop and produce new pharmaceutical forms and strengths. Every day more than 12,000 employees work on the quality, innovation and development of pharmaceutical products. By focusing on patient needs and requirements, our innovations facilitate treatment and improve patient adherence and therapy outcomes. The company was founded in 1954. Jože Colaric has been the CEO of the company since 2004. | Health Technology |